BioCryst Pharmaceuticals
BCRX
#4882
Rank
S$2.53 B
Marketcap
S$9.84
Share price
0.79%
Change (1 day)
5.02%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): S-$1.68

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$1.84. In 2022 the company made an earnings per share (EPS) of S-$1.70 a decrease over its 2021 EPS that were of S-$1.32.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$1.68-1.15%
2022S-$1.7029.13%
2021S-$1.32-4.63%
2020S-$1.3810.2%
2019S-$1.250%
2018S-$1.2525.64%
2017S-$1.004%
2016S-$0.9627.12%
2015S-$0.75-13.24%
2014S-$0.8723.64%
2013S-$0.70-30.38%
2012S-$1.01-37.3%
2011S-$1.6165.79%
2010S-$0.97117.14%
2009S-$0.45-46.15%
2008S-$0.83-26.97%
2007S-$1.14-40.67%
2006S-$1.9248.51%
2005S-$1.291%
2004S-$1.2838.89%
2003S-$0.92-25%
2002S-$1.23231.03%
2001S-$0.37-56.72%
2000S-$0.8691.43%
1999S-$0.452.94%
1998S-$0.44-55.84%
1997S-$0.9911.59%
1996S-$0.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
S-$3.97 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.68-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S-$3.37 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S-$0.26-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S-$1.94 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.57 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S-$0.56-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$4.07 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.40 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA